Last edition
News about
Granules India forays into pharma packaging operations in US
Granules will lease 79,000 sq ft of the Parkway 66 property at 7,413 Cushing Road in Manassas, and build out packaging lines and clean rooms to package and ship pharmaceuticals
Zydus Lifesciences bags US FDA approval for menopause drug
The drug will be manufactured in Moraiya, Ahmedabad, at the group's formulation manufacturing facility<br />
Innoforce opens GMP manufacturing facility and corp headquarters in Hangzhou, China
The company is investing a total of more than $200 million in its 550,000-square-foot advanced therapies manufacturing base with a full suite of technology platforms
<br />
Dipharma receives GMP certification from Brazilian ANVISA
The Baranzate site (Italy) is the first Dipharma manufacturing facility to receive Anvisa certification<br />
Shilpa Medicare's Telangana facility bags Health Canada GMP approval
The facility is involved in the manufacturing, packaging, labelling and testing of finished dosage forms
Akums enters into joint association with Leiutis and Biophore for therapeutics
The partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition to doctors and patients in India
Freudenberg Medical unveils HelixFlex at CPhI & PMEC India
TPE tubing is ideal for pharmaceutical bioprocessing applications
Zydus LifeSciences enters into BTA for purchase from Watson Pharma
The Business Undertaking was catering to the API requirements of Teva group and there was no external sale to third parties<br />
The event witnessed 50,000 visitors from across the globe, more than 1,500 exhibitors and representation from over 80 countries
Lupins' Brazilian arm buys nine brand rights from Bausch Health
Medqumica develops an extensive line of both solid and liquid medicines in Brazil
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy